Cardiovascular Diease and Metabolic disorders
GE Healthcare is developing or seeking products for the following areas of cardiology:
- Imaging of cardiac perfusion and function. Specific targets of interest include:
- Non-nuclear contrast agent for quantification of perfusion, so imaging can be dissociated from the stress procedure.
- Imaging of metabolic processes and receptor density/function for early detection and monitoring of heart disease
- Fibrotic disease
- Chronic inflammatory disease
Other cardiac imaging opportunities will be evaluated on an ad-hoc basis.